These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34652529)

  • 21. Influence of low molecular (below 5 KD) fraction from cord blood and actovegin on phagocytic activity of frozen-thawed neutrophils.
    Gulevsky AK; Moiseyeva NN; Gorina OL
    Cryo Letters; 2011; 32(2):131-40. PubMed ID: 21766142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience in the use of Actovegin in the treatment of patients with cognitive disorders in the acute period of stroke.
    Derev'yannykh EA; Bel'skaya GN; Knoll EA; Krylova LG; Popov DV
    Neurosci Behav Physiol; 2008 Oct; 38(8):873-5. PubMed ID: 18802768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antioxidant effect of cortexin, cerebrolysin and actovegin in rats with chronic cerebrovascular insufficiency].
    Kurkin DV; Morkovin EI; Kalatanova AV; Bakulin DA; Verholyak DV; Kovalev NS; Dubrovina MA; Tyurenkov IN; Petrov VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(7):84-89. PubMed ID: 34460162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleiotropic neuroprotective and metabolic effects of Actovegin's mode of action.
    Machicao F; Muresanu DF; Hundsberger H; Pflüger M; Guekht A
    J Neurol Sci; 2012 Nov; 322(1-2):222-7. PubMed ID: 22910148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Confirmed clinical efficacy of Actovegin in elderly patients with organic brain syndrome.
    Kanowski S; Kinzler E; Lehmann E; Schweizer A; Kuntz G
    Pharmacopsychiatry; 1995 Jul; 28(4):125-33. PubMed ID: 7491366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actovegin--Cutting-edge sports medicine or "voodoo" remedy?
    Lee P; Kwan A; Nokes L
    Curr Sports Med Rep; 2011 Jul; 10(4):186-90. PubMed ID: 23531892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effects of actovegin on cell proliferation of permanent lines].
    Gulevskiĭ AK; Trifonova AV; Lavrik AA
    Tsitol Genet; 2008; 42(1):53-7. PubMed ID: 18411759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodal approach to treatment of neurological complications of chronic brain ischemia.
    Tanashyan MM; Shabalina AA; Lagoda OV; Raskurazhev AA; Konovalov RN
    Ter Arkh; 2018 Dec; 90(12):61-67. PubMed ID: 30701835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of radiotherapy on IL-2 and IL-6 secretions of mucous membrane epithelial cells of wistar small intestine.
    Liu B; Li X; Ai F; Wang T; Chen Y; Zhang H
    Cell Biochem Biophys; 2015 Jan; 71(1):35-8. PubMed ID: 25081000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic efficiency of a combined use of low-intensity laser radiation and actovegin in gastroduodenal ulcers with inhibited cicatrix formation].
    Vakhrushev IaM; Shkatova EIu
    Ter Arkh; 2003; 75(9):86-9. PubMed ID: 14582442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of actovegin in the treatment of elderly patients with vascular mild cognitive impairment].
    Mikhaĭlova NM; Selezneva ND; Kalyn IaB; Roshchina IF; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):69-76. PubMed ID: 23994934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
    Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
    Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P2X7 receptor regulates EMMPRIN and MMP‑9 expression through AMPK/MAPK signaling in PMA‑induced macrophages.
    Lin L; Huang S; Zhu Z; Han J; Wang Z; Huang W; Huang Z
    Mol Med Rep; 2018 Sep; 18(3):3027-3033. PubMed ID: 30015874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design.
    Guekht A; Skoog I; Korczyn AD; Zakharov V; Eeg M; Vigonius U
    Dement Geriatr Cogn Dis Extra; 2013 Jan; 3(1):459-67. PubMed ID: 24516413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stimulatory effect of the cord blood fraction below 5 kDa and "Actovegin" on the growth of continuous cell lines].
    Gulevskiĭ AK; Trifonova AV; Lavrik AA
    Tsitologiia; 2011; 53(2):135-41. PubMed ID: 21516820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacoeconomic analysis of the neuroprotective medicines in the treatment of ischemic stroke].
    Yagudina RI; Kulikov AY; Krylov VA; Solovieva EY; Fedin AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7):60-68. PubMed ID: 31464291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of actovegin and solcoseryl on microcirculation in experimental critical lower limb ischaemia].
    Orlova AI; Sukovatykh BS; Artiushkova EB; Gordov MI
    Angiol Sosud Khir; 2017; 23(1):29-35. PubMed ID: 28574034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Actovegin in treatment of critical limb ischemia].
    Fomin AA; Pershakov DR
    Khirurgiia (Mosk); 2015; (8):54-57. PubMed ID: 26356060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topographic mapping of cognitive event-related potentials in a double-blind, placebo-controlled study with the hemoderivative Actovegin in age-associated memory impairment.
    Semlitsch HV; Anderer P; Saletu B; Hochmayer I
    Neuropsychobiology; 1990-1991; 24(1):49-56. PubMed ID: 2132641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calf Blood Compound (CFC) and Homeopathic Drug Induce Differentiation of Primary Human Skeletal Muscle Cells.
    Langendorf EK; Klein A; Rommens PM; Drees P; Ritz U; Mattyasovszky SG
    Int J Sports Med; 2019 Nov; 40(12):803-809. PubMed ID: 31476781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.